Dual gene expression cassette vectors with antibiotic selection markers for engineering in Saccharomyces cerevisiae

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Vickers, Claudia E ^a   Bydder, Sarah F ^a   Zhou, Yuchan ^a   Nielsen, Lars K ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antibiotic selection; Expression vector; G418; Phleomycin; Saccharomyces cerevisiae; Yeast

Indexed keywords

AMINOGLYCOSIDE PHOSPHOTRANSFERASE; ANTIBIOTIC AGENT; BETA GALACTOSIDASE; ENZYME; GALACTOSE; KANAMYCIN; NEOMYCIN; PHLEOMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; FERMENTATION; GENE CASSETTE; GENE EXPRESSION; METABOLIC ENGINEERING; NONHUMAN; PROMOTER REGION; RESTRICTION SITE; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

ESCHERICHIA COLI; GENE EXPRESSION; PHLEOMYCINS; PLASMIDS; PROMOTER REGIONS, GENETIC; SACCHAROMYCES CEREVISIAE;

EID: 84886125785     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-96     Document Type: Article

References (68)

1. Sherman F, et al. Yeast genetics. The encyclopedia of molecular biology and molecular medicine: volume 6 1997, 302-325. Weinheim, Germany: VCH Publisher.
2. Romanos MA, Scorer CA, Clare JJ. Foreign gene expression in yeast: a review. Yeast 1992, 8:423-488. 10.1002/yea.320080602, 1502852.
3. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943. 10.1038/nature04640, 16612385.
4. Hadfield C, Jordan BE, Mount RC, Pretorius GHJ, Burak E. G418-resistance as a dominant marker and reporter for gene expression in Saccharomyces cerevisiae. Curr Genet 1990, 18:303-313. 10.1007/BF00318211, 2174744.
5. Stansfield I, Stark MJR. Yeast gene analysis 2007, San Diego, CA: Academic Press, 2.
6. Jimenez A, Davies J. Expression of a transposable antibiotic-resistance element in Saccharomyces. Nature 1980, 287:869-871. 10.1038/287869a0, 6253817.
7. Bardazzi I, Casalone E. Construction of two new vectors for transformation of laboratory, natural and industrial Saccharomyces cerevisiae strains to trifluoroleucine and G418 resistance. Folia Microbiol (Praha) 2004, 49:534-538. 10.1007/BF02931529, 15702541.
8. Taxis C, Knop M. System of centromeric, episomal, and integrative vectors based on drug resistance markers for saccharomyces cerevisiae. Biotechniques 2006, 40:73-78. 10.2144/000112040, 16454043.
9. Sadowski I, Lourenco P, Parent J. Dominant marker vectors for selecting yeast mating products. Yeast 2008, 25:595-599. 10.1002/yea.1604, 18613257.
10. Baruffini E, Serafini F, Lodi T. Construction and characterization of centromeric, episomal and GFP-containing vectors for saccharomyces cerevisiae prototrophic strains. J Biotechnol 2009, 143:247-254. 10.1016/j.jbiotec.2009.08.007, 19683551.
11. Gritz L, Davies J. Plasmid-encoded hygromycin B resistance: the sequence of hygromycin B phosphotransferase gene and its expression in Escherichia coli and Saccharomyces cerevisiae. Gene 1983, 25:179-188. 10.1016/0378-1119(83)90223-8, 6319235.
12. Kaster KR, Burgett SG, Ingolia TD. Hygromycin-B resistance as dominant selectable marker in yeast. Curr Genet 1984, 8:353-358. 10.1007/BF00419824, 24177815.
13. Goldstein AL, McCusker JH. Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast 1999, 15:1541-1553. 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K, 10514571.
14. Carter Z, Delneri D. New generation of loxP-mutated deletion cassettes for the genetic manipulation of yeast natural isolates. Yeast 2010, 27:765-775. 10.1002/yea.1774, 20641014.
15. Gatignol A, Baron M, Tiraby G. Phleomycin resistance encoded by the ble gene from transposon Tn5 as a dominant selectable marker in Saccharomyces cerevisiae. Mol Gen Genet 1987, 207:342-348. 10.1007/BF00331599, 2441230.
16. Hadfield C, Cashmore AM, Meacock PA. An efficient chloramphenicol-resistance marker for Saccharomyces cerevisiae and Escherichia coli. Gene 1986, 45:149-158. 10.1016/0378-1119(86)90249-0, 3026903.
17. Hashida-Okado T, Ogawa A, Kato I, Takesako K. Transformation system for prototrophic industrial yeasts using the AUR1 gene as a dominant selection marker. FEBS Lett 1998, 425:117-122. 10.1016/S0014-5793(98)00211-7, 9541018.
18. Webster TD, Dickson RC. Direct selection of Saccharomyces cerevisiae resistant to the antibiotic G418 following transformation with a DNA vector carrying the kanamycin-resistance gene of Tn903. Gene 1983, 26:243-252. 10.1016/0378-1119(83)90194-4, 6323263.
19. Gatignol A, Dassain M, Tiraby G. Cloning of Saccharomyces cerevisiae promoters using a probe vector based on phleomycin resistance. Gene 1990, 91:35-41. 10.1016/0378-1119(90)90159-O, 1698168.
20. Gietz RD, Woods RA. Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method. Methods Enzymol 2002, 350:87-96.
21. Wenzel TJ, Migliazza A, Steensma HY, van den Berg JA. Efficient selection of phleomycin-resistant Saccharomyces cerevisiae transformants. Yeast 1992, 8:667-668. 10.1002/yea.320080810, 1441746.
22. Partow S, Siewers V, Bjørn S, Nielsen J, Maury J. Characterization of different promoters for designing a new expression vector in Saccharomyces cerevisiae. Yeast 2010, 27:955-964. 10.1002/yea.1806, 20625983.
23. Mikkelsen MD, Buron LD, Salomonsen B, Olsen CE, Hansen BG, Mortensen UH, Halkier BA. Microbial production of indolylglucosinolate through engineering of a multi-gene pathway in a versatile yeast expression platform. Metab Eng 2012, 14:104-111. 10.1016/j.ymben.2012.01.006, 22326477.
24. pESC vectors http://www.genomics.agilent.com/article.jsp?pageId=596.
25. Miller CA, Martinat MA, Hyman LE. Assessment of aryl hydrocarbon receptor complex interactions using pBEVY plasmids: expression vectors with bi-directional promoters for use in saccharomyces cerevisiae. Nucleic Acids Res 1998, 26:3577-3583. 10.1093/nar/26.15.3577, 147745, 9671822.
26. Li AM, Liu ZS, Li QX, Yu L, Wang DC, Deng XM. Construction and characterization of bidirectional expression vectors in saccharomyces cerevisiae. FEMS Yeast Res 2008, 8:6-9. 10.1111/j.1567-1364.2007.00335.x, 18031531.
27. Fang F, Salmon K, Shen MWY, Aeling KA, Ito E, Irwin B, Tran UPC, Hatfield GW, Da Silva NA, Sandmeyer S. A vector set for systematic metabolic engineering in Saccharomyces cerevisiae. Yeast 2011, 28:123-136. 10.1002/yea.1824, 3070743, 20936606.
28. Güldener U, Heck S, Fielder T, Beinhauer J, Hegemann JH. A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res 1996, 24:2519-2524. 10.1093/nar/24.13.2519, 145975, 8692690.
29. Gueldener U, Heinisch J, Koehler GJ, Voss D, Hegemann JH. A second set of loxP marker cassettes for cre-mediated multiple gene knockouts in budding yeast. Nucleic Acids Res 2002, 30:e23. 10.1093/nar/30.6.e23, 101367, 11884642.
30. EUROpean saccharomyces cerevisiae ARchive for functional analysis http://web.uni-frankfurt.de/fb15/mikro/euroscarf.
31. Behrendorff JBYH, Vickers CE, Chrysanthopoulos P, Nielsen LK. 2,2-Diphenyl-1-picrylhydrazyl as a screening tool for recombinant monoterpene biosynthesis. Microb Cell Fact 2013, 12:76. 10.1186/1475-2859-12-76, 10.1186/1475-2859-12-76, 23968454.
32. Diderich JA, Schepper M, van Hoek P, Luttik MA, van Dijken JP, Pronk JT, Klaassen P, Boelens HF, de Mattos MJ, van Dam K, Kruckeberg AL. Glucose uptake kinetics and transcription of HXT genes in chemostat cultures of Saccharomyces cerevisiae. J Biol Chem 1999, 274:15350-15359. 10.1074/jbc.274.22.15350, 10336421.
33. Sedlak M, Ho NWY. Characterization of the effectiveness of hexose transporters for transporting xylose during glucose and xylose co-fermentation by a recombinant Saccharomyces yeast. Yeast 2004, 21:671-684. 10.1002/yea.1060, 15197732.
34. Ye L, Berden JA, van Dam K, Kruckeberg AL. Expression and activity of the Hxt7 high-affinity hexose transporter of Saccharomyces cerevisiae. Yeast 2001, 18:1257-1267. 10.1002/yea.771, 11561293.
35. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 2012, 109:E111-E118. 10.1073/pnas.1110740109, 3271868, 22247290.
36. Ro D-K, Ouellet M, Paradise E, Burd H, Eng D, Paddon C, Newman J, Keasling J. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnol 2008, 8:83. 10.1186/1472-6750-8-83, 2588579, 18983675.
37. Lindahl AL, Olsson ME, Mercke P, Tollbom O, Schelin J, Brodelius M, Brodelius PE. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnol Lett 2006, 28:571-580. 10.1007/s10529-006-0015-6, 16614895.
38. Oka A, Sugisaki H, Takanami M. Nucleotide sequence of the kanamycin resistance transposon Tn903. J Mol Biol 1981, 147:217-226. 10.1016/0022-2836(81)90438-1, 6270337.
39. Wach A, Brachat A, Pohlmann R, Philippsen P. New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast 1994, 10:1793-1808. 10.1002/yea.320101310, 7747518.
40. Magnet S, Blanchard JS. Molecular insights into aminoglycoside action and resistance. ChemInform 2005, 105:477-496. no-no.
41. Lang-Hinrichs C, Berndorff D, Seefeldt C, Stahl U. G418 resistance in the yeast Saccharomyces cerevisiae: comparison of the neomycin resistance genes from Tn5 and Tn903. Appl Microbiol Biotechnol 1989, 30:388-394.
42. Verduyn C, Postma E, Scheffers WA, Van Dijken JP. Effect of benzoic acid on metabolic fluxes in yeasts: a continuous-culture study on the regulation of respiration and alcoholic fermentation. Yeast 1992, 8:501-517. 10.1002/yea.320080703, 1523884.
43. Sherman F. Getting started with yeast. Methods Enzymol 2002, 350:3-41.
44. Cheng TH, Chang CR, Joy P, Yablok S, Gartenberg MR. Controlling gene expression in yeast by inducible site-specific recombination. Nucleic Acids Res 2000, 28:E108. 10.1093/nar/28.24.e108, 115252, 11121495.
45. G418 sulfate product insert http://www.invivogen.com/PDF/G418_TDS.pdf.
46. Genilloud O, Garrido MC, Moreno F. The transposon Tn5 carries a bleomycin-resistance determinant. Gene 1984, 32:225-233. 10.1016/0378-1119(84)90050-7, 6085062.
47. Collis CM, Hall RM. Identification of a Tn5 determinant conferring resistance to phleomycins, bleomycins, and tallysomycins. Plasmid 1985, 14:143-151. 10.1016/0147-619X(85)90074-5, 2415995.
48. Mazodier P, Cossart P, Giraud E, Gasser F. Completion of the nucleotide sequence of the central region of Tn5 confirms the presence of three resistance genes. Nucleic Acids Res 1985, 13:195-205. 10.1093/nar/13.1.195, 340984, 3889831.
49. Stern R, Rose JA, Friedman RM. Phleomycin-induced cleavage of deoxyribonucleic acid. Biochemistry 1974, 13:307-312. 10.1021/bi00699a012, 4855655.
50. Povirk LF, Hogan M, Dattagupta N, Buechner M. Copper(II).bleomycin, iron(III).bleomycin, and copper(II) phleomycin: comparative study of deoxyribonucleic acid binding. Biochemistry 1981, 20:665-671. 10.1021/bi00506a034, 6163448.
51. Sleigh MJ. The mechanism of DNA breakage by phleomycin in vitro. Nucleic Acids Res 1976, 3:891-901. 10.1093/nar/3.4.891, 342953, 818624.
52. Moore CW. Control of in vivo (cellular) phleomycin sensitivity by nuclear genotype, growth phase, and metal ions. Cancer Res 1982, 42:929-933.
53. Gatignol A, Durand H, Tiraby G. Bleomycin resistance conferred by a drug-binding protein. FEBS Lett 1988, 230:171-175. 10.1016/0014-5793(88)80665-3, 2450783.
54. He ZM, Price MS, Obrian GR, Georgianna DR, Payne GA. Improved protocols for functional analysis in the pathogenic fungus Aspergillus flavus. BMC Microbiol 2007, 7:104. 10.1186/1471-2180-7-104, 2212646, 18039373.
55. Da Silva NA, Srikrishnan S. Introduction and expression of genes for metabolic engineering applications in Saccharomyces cerevisiae. FEMS Yeast Res 2012, 12:197-214. 10.1111/j.1567-1364.2011.00769.x, 22129153.
56. Belenguer P, Oustrin M-L, Tiraby G, Ducommun B. Effects of phleomycin-induced DNA damage on the fission yeast Schizosaccharomyces pombe cell cycle. Yeast 1995, 11:225-231. 10.1002/yea.320110305, 7785323.
57. Hua J, Meyer JD, Lodge JK. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans. Clin Diagn Lab Immunol 2000, 7:125-128. 95837, 10618292.
58. Austin B, Hall RM, Tyler BM. Optimized vectors and selection for transformation of Neurospora crassa and Aspergillus nidulans to bleomycin and phleomycin resistance. Gene 1990, 93:157-162. 10.1016/0378-1119(90)90152-H, 1699844.
59. Kim B-G, Joh J-H, Yoo Y-B, Magae Y. Transformation of the edible basidiomycete, Pleurotus ostreatus to phleomycin resistance. Mycobiology 2003, 31:42-45.
60. Sambrook J, Russell DW. Molecular cloning: a laboratory manual 2001, Cold Spring Harbour, NY: Cold Spring Harbor Laboratory Press, 3.
61. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000, 97:6640-6645. 10.1073/pnas.120163297, 18686, 10829079.
62. Muyrers JPP, Zhang Y, Stewart AF. Techniques: recombinogenic engineering - new options for cloning and manipulating DNA. Trends Biochem Sci 2001, 26:325-331. 10.1016/S0968-0004(00)01757-6, 11343926.
63. Thomason L, Court DL, Bubunenko M, Costantino N, Wilson H, Datta S, Oppenheim A. Recombineering: genetic engineering in bacteria using homologous recombination 2007, Current protocols in molecular biology, http://www.ncbi.nlm.nih.gov/pubmed/18265390.
64. Oliner JD, Kinzler KW, Vogelstein B. In vivo cloning of PCR products in E. coli. Nucleic Acids Res 1993, 21:5192-5197. 10.1093/nar/21.22.5192, 310636, 8255776.
65. Bruschi M, Boyes S, Sugiarto H, Nielsen LK, Vickers CE. A transferrable sucrose utilization approach for non-sucrose-utilizing Escherichia coli strains. Biotech Adv 2011, 30:1001-1010.
66. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/0003-2697(76)90527-3, 942051.
67. Griffith KL, Wolf RE. Measuring beta-galactosidase activity in bacteria: cell growth, permeabilization, and enzyme assays in 96-well arrays. Biochem Biophys Res Commun 2002, 290:397-402. 10.1006/bbrc.2001.6152, 11779182.
68. Miller JH. Experiments in molecular genetics 1972, Cold Spring Harbour Labratory: Cold Spring Harbour, NY.